To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ILVBLTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
324 supporting clones for gene ILVBL back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP374475 umbilical cord .a 1 to 583 1 to 582   tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
DB445988 testis .a 15 to 447 1 to 435       435/435
(100 %)
9 diff
(98.0 %id)
BF568165 epithelioid carcinoma cell line, Pancreas .a 20 to 859 1 to 839       839/1125
(74 %)
35 diff
(96.9 %id)
BC011722 Pancreas, epithelioid carcinoma .a 21 to 2305 1 to 2284 exact tiling clone, available from MGC, AAA   2284/2284
(100 %)
3 diff
(99.9 %id)
NM_006844.3   .a 21 to 2317 1 to 2296 exact RefSeq, AAA   2296/2296
(100 %)
1 diff
(100.0 %id)
BE794174 lung, small cell carcinoma .a 36 to 856 1 to 814       814/1037
(78 %)
18 diff
(98.3 %id)
BE270730 Burkitt lymphoma, lymph .a 73 to 788 1 to 710       710/735
(96 %)
21 diff
(97.2 %id)
CN406870 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 75 to 549 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
BP214562 corpus callosum .a 78 to 663 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BG827258 muscle, rhabdomyosarcoma .a 84 to 871 1 to 791       791/940
(84 %)
66 diff
(93.0 %id)
BI194139 epithelioid carcinoma cell line, Pancreas .a 85 to 858 1 to 777       779/854
(91 %)
29 diff
(96.7 %id)
BE616799 adenocarcinoma, Pancreas .a 89 to 885 28 to 813       786/863
(91 %)
31 diff
(96.5 %id)
BI114674 muscle, rhabdomyosarcoma .a 89 to 663 1 to 584       584/944
(61 %)
21 diff
(97.8 %id)
BI196920 brain, neuroblastoma .a 92 to 574 1 to 489       489/492
(99 %)
10 diff
(98.0 %id)
BI198909 brain, neuroblastoma .a 92 to 815 1 to 717       717/827
(86 %)
20 diff
(97.6 %id)
BC011761 Pancreas, adenocarcinoma .a 95 to 2305 1 to 2210 N374D available from MGC, AAA   2210/2210
(100 %)
5 diff
(99.8 %id)
BE262560 brain, neuroblastoma .a 97 to 753 40 to 692       653/734
(88 %)
14 diff
(98.1 %id)
BQ677304 melanotic melanoma, cell line, skin .a 103 to 748 1 to 645       645/954
(67 %)
9 diff
(99.1 %id)
BQ679083 melanotic melanoma, cell line, skin .a 103 to 864 1 to 761       761/901
(84 %)
21 diff
(97.7 %id)
BE270276 Burkitt lymphoma, lymph .a 104 to 747 1 to 646       646/680
(95 %)
8 diff
(98.9 %id)
DR004612 placenta .a 106 to 731 1 to 625       625/625
(100 %)
11 diff
(98.3 %id)
U61263 fetal brain .a 113 to 2305 1 to 2192 G199X AAA   2192/2192
(100 %)
4 diff
(99.9 %id)
BU557011 ovary, teratocarcinoma, cell line .a 123 to 955 1 to 842       842/978
(86 %)
19 diff
(98.1 %id)
BF314261 brain, neuroblastoma .a 137 to 753 1 to 610       610/923
(66 %)
16 diff
(98.3 %id)
BE255101 eye, retinoblastoma .a 139 to 796 1 to 651       651/652
(99 %)
13 diff
(98.1 %id)
BU857576 adenocarcinoma, cell line, breast .a 142 to 959 1 to 831       831/938
(88 %)
18 diff
(98.1 %id)
BU859984 adenocarcinoma, cell line, breast .a 142 to 539 1 to 404       404/948
(42 %)
12 diff
(98.8 %id)
TI_1948081239   .a 142 to 859 132 to 854       723/1292
(55 %)
21 diff
(98.4 %id)
TI_1948081418   .a 142 to 787 140 to 790       651/1461
(44 %)
13 diff
(99.2 %id)
TI_1948081592   .a 142 to 754 128 to 740       613/1358
(45 %)
17 diff
(98.8 %id)
TI_1948154456   .a 142 to 754 130 to 742       613/1352
(45 %)
52 diff
(96.2 %id)
TI_1948154611   .a 142 to 1057 125 to 1040   AAA   916/1331
(68 %)
21 diff
(98.5 %id)
TI_1948154932   .a 142 to 1057 125 to 1050       926/1343
(68 %)
30 diff
(97.8 %id)
TI_1948081064   .a 143 to 859 131 to 851       721/1282
(56 %)
24 diff
(98.2 %id)
TI_157602769   .a 155 to 745 73 to 665     Submitted on the opposite strand 593/1135
(52 %)
26 diff
(97.8 %id)
TI_158433552   .a 155 to 611 43 to 499     Submitted on the opposite strand 457/1134
(40 %)
11 diff
(99.1 %id)
TI_159707652   .a 155 to 943 59 to 840     Submitted on the opposite strand 782/1092
(71 %)
23 diff
(97.9 %id)
AW291633   .a 156 to 508 1 to 353     Submitted on the opposite strand 353/353
(100 %)
0 diff
(100 %id)
BF448567 fibrotheoma, ovary .a 156 to 786 1 to 631     Submitted on the opposite strand 631/632
(99 %)
15 diff
(97.7 %id)
BE261780 brain, neuroblastoma .a 157 to 800 1 to 641       641/642
(99 %)
10 diff
(98.5 %id)
BE313450 brain, neuroblastoma .a 157 to 639 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BE312622 brain, neuroblastoma .a 158 to 811 1 to 649       649/660
(98 %)
14 diff
(97.9 %id)
BE261335 brain, neuroblastoma .a 160 to 605 1 to 446       446/446
(100 %)
0 diff
(100 %id)
BE382626 brain, neuroblastoma .a 161 to 633 1 to 473       473/473
(100 %)
2 diff
(99.6 %id)
AI190130 heart .a 173 to 585 1 to 413     Submitted on the opposite strand 413/414
(99 %)
5 diff
(98.8 %id)
N89966 parathyroid gland, parathyroid tumor .a 185 to 524 1 to 344     Submitted on the opposite strand 344/344
(100 %)
9 diff
(97.4 %id)
N91760 lung .a 185 to 400 1 to 220     Submitted on the opposite strand 220/220
(100 %)
6 diff
(97.3 %id)
AI027531 parathyroid gland, parathyroid tumor .a 185 to 773 1 to 591     Submitted on the opposite strand 591/595
(99 %)
5 diff
(99.2 %id)
AI150763 heart .a 185 to 661 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
AI188869 placenta .a 185 to 745 1 to 561     Submitted on the opposite strand 561/561
(100 %)
11 diff
(98.1 %id)
AI471014 brain, glioblastoma (pooled) .a 185 to 415 1 to 231     Submitted on the opposite strand 231/231
(100 %)
0 diff
(100 %id)
AI566186 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 185 to 744 1 to 560     Submitted on the opposite strand 560/561
(99 %)
11 diff
(98.1 %id)
AI831284 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 185 to 643 1 to 460     Submitted on the opposite strand 460/460
(100 %)
2 diff
(99.6 %id)
AI991644 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 185 to 475 1 to 293     Submitted on the opposite strand 293/293
(100 %)
2 diff
(99.4 %id)
BF058870 fibrotheoma, ovary .a 185 to 748 1 to 564     Submitted on the opposite strand 564/588
(95 %)
5 diff
(99.2 %id)
AW271472 Kidney .a 187 to 744 1 to 557     Submitted on the opposite strand 557/565
(98 %)
10 diff
(98.3 %id)
CA487362   .a 201 to 969 1 to 772       772/873
(88 %)
9 diff
(99.0 %id)
AA887424 Kidney .a 229 to 430 1 to 202     Submitted on the opposite strand 202/202
(100 %)
3 diff
(98.6 %id)
BM541865 leiomyosarcoma, uterus .a 242 to 1054 1 to 826       826/1058
(78 %)
17 diff
(98.4 %id)
BC126913 PCR rescued clones .a 264 to 975 16 to 727       712/727
(97 %)
10 diff
(98.7 %id)
BE268789 Burkitt lymphoma, lymph .a 272 to 935 1 to 659       659/713
(92 %)
21 diff
(97.1 %id)
AW732672 Burkitt lymphoma, lymph .a 289 to 834 1 to 547       547/547
(100 %)
5 diff
(99.1 %id)
CN406867 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 290 to 1044 1 to 751       751/751
(100 %)
3 diff
(99.7 %id)
BE271297 Burkitt lymphoma, lymph .a 330 to 942 126 to 753       626/880
(71 %)
35 diff
(96.1 %id)
CX788876 human embryonic stem cells .a 368 to 1145 8 to 785       778/785
(99 %)
7 diff
(99.2 %id)
AW081042 colon, moderately differentiated adenocarcinoma .a 384 to 607 1 to 224     Submitted on the opposite strand 224/230
(97 %)
5 diff
(97.9 %id)
AW301111 colon, moderately differentiated adenocarcinoma .a 384 to 816 1 to 433     Submitted on the opposite strand 434/434
(100 %)
16 diff
(96.4 %id)
CR608986 Neuroblastoma Cot 25-normalized .a 410 to 2266 1 to 1857   tiling clone,   1857/1857
(100 %)
0 diff
(100 %id)
BX364533 Neuroblastoma Cot 25-normalized .a 410 to 1332 1 to 923   fully sequenced,   923/923
(100 %)
3 diff
(99.7 %id)
BF310206 brain, neuroblastoma .a 426 to 1129 1 to 691       691/918
(75 %)
19 diff
(98.0 %id)
BF312805 brain, neuroblastoma .a 426 to 1168 1 to 738       738/900
(82 %)
31 diff
(96.6 %id)
CN406869 embryonic stem cells, DMSO-treated H9 cellline .a 464 to 1095 9 to 640       632/640
(98 %)
0 diff
(100 %id)
TI_151786391   .a 491 to 1192 103 to 798       696/923
(75 %)
17 diff
(98.2 %id)
BX372336   .a 508 to 1417 903 to 1       903/903
(100 %)
18 diff
(98.1 %id)
F05377 brain, total brain .a 543 to 761 1 to 219       219/219
(100 %)
2 diff
(99.1 %id)
AA853086 Bone, Hip .a 543 to 818 1 to 277       277/277
(100 %)
8 diff
(97.2 %id)
BG476451 melanotic melanoma, skin .a 548 to 1381 1 to 840       804/847
(94 %)
19 diff
(97.8 %id)
BI193891 epithelioid carcinoma cell line, Pancreas .a 552 to 1327 1 to 779       779/841
(92 %)
15 diff
(98.3 %id)
CA396563 eye, RPE/choroid .a 586 to 1093 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
CV800759 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 587 to 1319 1 to 722       722/840
(85 %)
12 diff
(98.6 %id)
BG248085 adenocarcinoma cell line, colon .a 657 to 1444 1 to 781       781/896
(87 %)
23 diff
(97.5 %id)
BG469220 adenocarcinoma cell line, colon .a 657 to 1385 1 to 728       728/731
(99 %)
8 diff
(99.0 %id)
CR609878 Neuroblastoma Cot 50-normalized .a 684 to 2297 1 to 1614       1614/1614
(100 %)
0 diff
(100 %id)
AL530271 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 684 to 1526 1 to 841   fully sequenced,   841/841
(100 %)
13 diff
(98.5 %id)
BF920772 nervous_tumor .a 688 to 960 310 to 39     Submitted on the opposite strand 272/332
(81 %)
2 diff
(99.4 %id)
BG824197 adenocarcinoma cell line, colon .a 707 to 1545 1 to 837       837/839
(99 %)
12 diff
(98.6 %id)
BI760062 pooled colon, kidney, stomach .a 729 to 1549 1 to 823       825/823
(100 %)
15 diff
(98.2 %id)
TI_57147559   .a 729 to 1549 74 to 896       823/896
(91 %)
19 diff
(97.9 %id)
CA489605   .a 744 to 1611 31 to 909       881/940
(93 %)
30 diff
(96.9 %id)
BX362736   .a 794 to 1714 1 to 920       920/920
(100 %)
2 diff
(99.8 %id)
AA351950 brain .a 813 to 1284 1 to 475       475/475
(100 %)
4 diff
(99.2 %id)
R14923 whole brain .a 815 to 1173 1 to 361       361/361
(100 %)
9 diff
(97.6 %id)
BQ709472 Spleen .a 815 to 1612 1 to 808       808/946
(85 %)
16 diff
(98.4 %id)
BQ882258 Spleen .a 815 to 1540 1 to 731       731/920
(79 %)
11 diff
(98.9 %id)
BQ706441 Spleen .a 815 to 1686 1 to 880       877/914
(95 %)
17 diff
(98.2 %id)
BM721585 eye, fetal eye .a 842 to 1259 1 to 418       418/418
(100 %)
0 diff
(100 %id)
CA392622 eye, RPE/choroid .a 848 to 1527 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
BF311622 brain, neuroblastoma .a 848 to 1593 1 to 753       753/858
(87 %)
17 diff
(98.1 %id)
BE260769 brain, neuroblastoma .a 868 to 1364 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BF763942 colon_est .a 905 to 1168 1 to 264       264/338
(78 %)
2 diff
(99.5 %id)
BI194681 epithelioid carcinoma cell line, Pancreas .a 958 to 1332 1 to 375       375/629
(59 %)
7 diff
(98.9 %id)
BM050050 epithelioid carcinoma cell line, Pancreas .a 958 to 1684 1 to 731       731/1141
(64 %)
15 diff
(98.7 %id)
BU589580 mixed (pool of 40 RNAs) .a 958 to 1680 26 to 753       726/992
(73 %)
25 diff
(97.5 %id)
CA487198   .a 985 to 1855 1 to 879       879/882
(99 %)
33 diff
(96.3 %id)
CA487283   .a 985 to 1921 1 to 937       937/942
(99 %)
27 diff
(97.2 %id)
BX349245   .a 992 to 1756 1 to 763       765/952
(80 %)
18 diff
(98.2 %id)
AA412226.
matches multiple genes
  .a 1019 to 1089 1 to 70     also hits gene CKS1B 70/70
(100 %)
1 diff
(98.6 %id)
BG820951 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1026 to 1755 1 to 737       737/946
(77 %)
17 diff
(98.3 %id)
CX758859 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1040 to 1758 1 to 718     Submitted on the opposite strand 720/718
(100 %)
4 diff
(99.5 %id)
AA424288 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1067 to 1266 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
BX093429 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1070 to 1807 1 to 739       739/739
(100 %)
3 diff
(99.6 %id)
T07403   .a 1070 to 1332 272 to 10       263/272
(96 %)
0 diff
(100 %id)
BE548384 cervical carcinoma cell line, cervix .a 1086 to 1864 1 to 790       790/796
(99 %)
39 diff
(95.2 %id)
BF991644 placenta_normal .a 1091 to 1501 421 to 9       413/450
(91 %)
11 diff
(97.6 %id)
BM465752 eye, retinoblastoma .a 1097 to 1614 12 to 531       520/1024
(50 %)
14 diff
(98.7 %id)
CA453946   .a 1102 to 1974 25 to 909       885/916
(96 %)
29 diff
(96.9 %id)
T32910 adrenal gland .a 1121 to 1453 1 to 334       334/338
(98 %)
8 diff
(97.7 %id)
TI_151770487   .a 1130 to 1681 108 to 661       554/1157
(47 %)
20 diff
(98.3 %id)
CN406864 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1143 to 1672 1 to 530       530/530
(100 %)
4 diff
(99.3 %id)
BM510305 insulinoma, Pancreas .a 1147 to 1686 8 to 547       540/548
(98 %)
3 diff
(99.5 %id)
CB163040 Liver .a 1151 to 1443 1 to 293       293/293
(100 %)
0 diff
(100 %id)
BQ055977 lymph, lymphoma, cell line .a 1168 to 1919 1 to 757       757/1077
(70 %)
10 diff
(99.1 %id)
BQ063134 lymph, lymphoma, cell line .a 1168 to 2039 1 to 884       884/1048
(84 %)
14 diff
(98.7 %id)
BM263197 Islets of Langerhans, Pancreas .a 1170 to 1747 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
AA079583   .a 1181 to 1590 1 to 408       408/408
(100 %)
7 diff
(98.3 %id)
TI_154181809   .a 1182 to 1861 70 to 747       678/869
(78 %)
25 diff
(97.2 %id)
TI_1948081240   .a 1185 to 2040 987 to 124       862/1306
(66 %)
27 diff
(98.0 %id)
TI_1948081419   .a 1185 to 2040 970 to 110       861/1292
(66 %)
32 diff
(97.6 %id)
BF346916 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1189 to 1954 1 to 765       765/765
(100 %)
11 diff
(98.6 %id)
CF122285 CNCAP(3)T-225 cell line, Prostate .a 1191 to 1727 18 to 554       541/554
(97 %)
17 diff
(97.0 %id)
TI_1948081593   .a 1191 to 2040 971 to 122       850/1338
(63 %)
14 diff
(99.0 %id)
TI_1948154612   .a 1191 to 2040 976 to 128       849/1273
(66 %)
7 diff
(99.5 %id)
TI_1948154933   .a 1200 to 2040 967 to 125       843/1282
(65 %)
7 diff
(99.5 %id)
BM853410 Ascites, stomach .a 1203 to 1792 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
BM705314 eye, RPE and Choroid .a 1203 to 1641 1 to 439       439/439
(100 %)
2 diff
(99.6 %id)
CF127556 Chondrosarcoma Lung Metastasis cell lines, lung .a 1221 to 2001 1 to 779       779/781
(99 %)
5 diff
(99.4 %id)
TI_154193083   .a 1221 to 2069 51 to 890       840/999
(84 %)
11 diff
(98.9 %id)
BF305392 muscle, rhabdomyosarcoma .a 1235 to 2049 1 to 810       810/810
(100 %)
24 diff
(97.1 %id)
BX343017   .a 1262 to 2277 1011 to 1       1011/1011
(100 %)
9 diff
(99.2 %id)
BQ083166 Ascites, stomach .a 1271 to 1737 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BF525499 brain, glioblastoma with EGFR amplification .a 1276 to 2076 1 to 815       728/983
(74 %)
50 diff
(95.0 %id)
BF724518 eye, Iris .a 1282 to 1804 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
BX364532 Neuroblastoma Cot 25-normalized .a 1298 to 2266 968 to 1   fully sequenced,   968/968
(100 %)
4 diff
(99.6 %id)
BE906843 epithelioid carcinoma, Pancreas .a 1299 to 1937 1 to 639       639/640
(99 %)
1 diff
(99.9 %id)
CN406871 embryonic stem cells, DMSO-treated H9 cellline .a 1301 to 1533 1 to 233       233/233
(100 %)
0 diff
(100 %id)
BM826698 Ascites, stomach .a 1323 to 1917 5 to 598       593/598
(99 %)
8 diff
(98.7 %id)
TI_1948154457   .a 1326 to 2040 848 to 127       722/1314
(54 %)
21 diff
(98.5 %id)
BM558802 eye, retinoblastoma .a 1331 to 2306 995 to 5     Submitted on the opposite strand 991/1014
(97 %)
30 diff
(97.1 %id)
BM797847 Ascites, stomach .a 1337 to 1552 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
BX346329   .a 1341 to 2274 928 to 1       928/928
(100 %)
18 diff
(98.1 %id)
BQ302778 breast .a 1360 to 1783 1 to 424       424/426
(99 %)
4 diff
(99.1 %id)
BI041938 nervous_tumor .a 1374 to 1702 329 to 1       329/329
(100 %)
2 diff
(99.4 %id)
CR615100 fetal brain .a 1380 to 2306 1 to 927       927/927
(100 %)
0 diff
(100 %id)
AL566043 brain, fetal brain .a 1380 to 2306 1 to 926       926/926
(100 %)
5 diff
(99.5 %id)
BM474859 duodenal adenocarcinoma, cell line, small intestine .a 1428 to 2309 1 to 888   AAA   888/888
(100 %)
17 diff
(98.1 %id)
BF984792 duodenal adenocarcinoma, cell line, small intestine .a 1432 to 2206 1 to 782       782/1060
(73 %)
29 diff
(97.3 %id)
BE791510 lung, small cell carcinoma .a 1434 to 1880 1 to 447       447/447
(100 %)
0 diff
(100 %id)
BE795219 lung, small cell carcinoma .a 1434 to 2210 1 to 771       771/773
(99 %)
11 diff
(98.6 %id)
CN406866 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1438 to 1743 1 to 305       304/305
(99 %)
4 diff
(98.7 %id)
AI376716   .a 1443 to 2311 870 to 5       866/886
(97 %)
33 diff
(96.3 %id)
TI_1948081065   .a 1445 to 2040 725 to 124       602/1411
(42 %)
8 diff
(99.5 %id)
BF568890 epithelioid carcinoma cell line, Pancreas .a 1452 to 2272 835 to 18       816/1036
(78 %)
33 diff
(96.9 %id)
AL530270 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 1496 to 2297 803 to 1   fully sequenced,   803/803
(100 %)
13 diff
(98.4 %id)
CX760050 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1526 to 2251 1 to 726     Submitted on the opposite strand 726/726
(100 %)
1 diff
(99.9 %id)
AW071884 anaplastic oligodendroglioma, brain .a 1529 to 2305 776 to 1       776/776
(100 %)
16 diff
(98.0 %id)
CN485138 eye .a 1534 to 2124 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
TI_154015751   .a 1535 to 2315 864 to 92   AAA   773/992
(77 %)
12 diff
(98.8 %id)
BM069758 Islets of Langerhans, Pancreas .a 1566 to 2041 1 to 476   fully sequenced,   476/476
(100 %)
0 diff
(100 %id)
BM826930 Ascites, stomach .a 1607 to 1958 1 to 352       352/352
(100 %)
0 diff
(100 %id)
BE271098 Burkitt lymphoma, lymph .a 1613 to 2240 655 to 16       640/983
(65 %)
6 diff
(99.4 %id)
TI_159702788   .a 1614 to 2305 822 to 134   AAA   689/924
(74 %)
23 diff
(97.6 %id)
T99882 liver and spleen .a 1617 to 1968 1 to 355   fully sequenced,   353/353
(100 %)
10 diff
(97.2 %id)
TI_159696418   .a 1623 to 2305 741 to 60   AAA   682/982
(69 %)
3 diff
(99.7 %id)
TI_149277769   .a 1626 to 2315 777 to 90   AAA   688/689
(99 %)
5 diff
(99.3 %id)
CA437057 lung, Metastatic Chondrosarcoma .a 1630 to 2315 704 to 19   AAA   686/686
(100 %)
0 diff
(100 %id)
BP432254   .a 1640 to 2007 8 to 381       374/381
(98 %)
13 diff
(96.6 %id)
AW878255 ovary .a 1656 to 2189 1 to 536       536/536
(100 %)
10 diff
(98.2 %id)
BU630918 cell lines, Chondrosarcoma .a 1658 to 2305 665 to 19   AAA   647/647
(100 %)
1 diff
(99.9 %id)
CA450443 Human Lung Epithelial cells, lung .a 1660 to 2305 662 to 19   AAA   644/644
(100 %)
2 diff
(99.7 %id)
BM676342 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1666 to 2317 670 to 19   AAA   652/653
(99 %)
0 diff
(100 %id)
BM710253 eye, RPE and Choroid .a 1669 to 2183 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BF589771 sciatic nerve .a 1679 to 2305 640 to 16   AAA   625/674
(92 %)
9 diff
(98.7 %id)
TI_151775848   .a 1683 to 2301 104 to 726       624/1141
(54 %)
13 diff
(98.9 %id)
AW081099 colon, moderately differentiated adenocarcinoma .a 1684 to 2305 631 to 13   AAA   619/631
(98 %)
13 diff
(98.0 %id)
AA365810 pineal body .a 1685 to 2012 1 to 332       332/334
(99 %)
5 diff
(98.6 %id)
AW953996   .a 1685 to 2306 1 to 612       612/632
(96 %)
29 diff
(95.5 %id)
AA733053 heart .a 1685 to 2283 599 to 1       599/614
(97 %)
15 diff
(97.6 %id)
CV802927 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1701 to 2305 622 to 21   AAA Submitted on the opposite strand 602/793
(75 %)
8 diff
(99.0 %id)
BU677939 lung .a 1704 to 2315 630 to 19   AAA   612/612
(100 %)
1 diff
(99.9 %id)
BE675645 B-cell, chronic lymphotic leukemia .a 1706 to 2036 331 to 1       331/337
(98 %)
6 diff
(98.3 %id)
BU732666 eye, optic nerve .a 1715 to 2305 609 to 19   AAA   591/591
(100 %)
1 diff
(99.9 %id)
BM725588 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1722 to 2286 1 to 565   fully sequenced,   565/565
(100 %)
0 diff
(100 %id)
AW172755 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1727 to 2305 603 to 22   AAA   582/582
(100 %)
23 diff
(96.1 %id)
EC553274 Prostate .a 1733 to 1823 1 to 91       91/91
(100 %)
0 diff
(100 %id)
TI_157604700   .a 1750 to 2305 661 to 106   AAA   556/713
(77 %)
11 diff
(98.5 %id)
AI742656 pooled .a 1755 to 2319 568 to 2       567/612
(92 %)
11 diff
(98.3 %id)
TI_151749905   .a 1755 to 2317 687 to 119   AAA   569/668
(85 %)
19 diff
(97.2 %id)
CA426711 cell lines, Chondrosarcoma .a 1756 to 2305 569 to 19   AAA   551/551
(100 %)
6 diff
(99.0 %id)
BM142479 Islets of Langerhans, Pancreas .a 1757 to 2305 561 to 13   AAA   549/549
(100 %)
0 diff
(100 %id)
T35376 brain .a 1761 to 2087 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
BF035425 adenocarcinoma, ovary .a 1762 to 2306 1 to 545       545/687
(79 %)
1 diff
(99.9 %id)
AW375824 colon .a 1765 to 1964 199 to 5       195/203
(96 %)
5 diff
(97.6 %id)
AA778935 liver and spleen .a 1770 to 2301 531 to 1       531/532
(99 %)
5 diff
(99.1 %id)
TI_151750187   .a 1770 to 2309 615 to 74   AAA   542/1309
(41 %)
7 diff
(99.5 %id)
BE300616 Burkitt lymphoma, lymph .a 1778 to 2306 532 to 4       529/532
(99 %)
4 diff
(99.3 %id)
AA535315 colon .a 1786 to 2305 520 to 1       520/520
(100 %)
10 diff
(98.1 %id)
AW080539 colon, moderately differentiated adenocarcinoma .a 1787 to 2305 519 to 1       519/519
(100 %)
16 diff
(97.0 %id)
BG283867 adenocarcinoma, cell line, Prostate .a 1788 to 2288 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BG058598 blood, lymphocyte .a 1792 to 2305 528 to 14   AAA   515/520
(99 %)
22 diff
(95.8 %id)
BM669043 eye, RPE and Choroid .a 1794 to 2309 534 to 19   AAA   516/516
(100 %)
0 diff
(100 %id)
BM678062 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1795 to 2311 533 to 17   fully sequenced, AAA   517/517
(100 %)
0 diff
(100 %id)
AA919134 Kidney .a 1811 to 2306 497 to 2       496/497
(99 %)
3 diff
(99.4 %id)
AW172678 bowel (skin primary), metastatic melanoma to bowel .a 1811 to 2036 226 to 1       226/226
(100 %)
11 diff
(95.2 %id)
TI_157605098   .a 1813 to 2305 602 to 110   AAA   493/494
(99 %)
3 diff
(99.4 %id)
AI084533   .a 1814 to 2171 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
AI471264 colon, moderately-differentiated adenocarcinoma .a 1829 to 2305 474 to 1       474/474
(100 %)
4 diff
(99.2 %id)
AI081301 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1835 to 2311 478 to 2       477/478
(99 %)
0 diff
(100 %id)
AA316416 colon .a 1855 to 2072 1 to 218       218/218
(100 %)
0 diff
(100 %id)
DB537064 hippocampus .a 1862 to 2304 7 to 450     Submitted on the opposite strand 444/451
(98 %)
9 diff
(98.1 %id)
AI559510 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1862 to 2305 454 to 11   AAA   444/444
(100 %)
1 diff
(99.8 %id)
CF529629 placenta .a 1862 to 2305 462 to 19   AAA   444/449
(98 %)
2 diff
(99.6 %id)
BM677203 eye, fetal eye .a 1862 to 2309 467 to 19   AAA   449/454
(98 %)
3 diff
(99.4 %id)
T12182   .a 1863 to 2045 1 to 182       182/187
(97 %)
5 diff
(97.4 %id)
BM855229 stomach .a 1863 to 2153 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
AI284396 Kidney .a 1865 to 2306 439 to 1       439/439
(100 %)
23 diff
(94.8 %id)
AI224365 lymph node, lymphoma, follicular mixed small and largecell .a 1865 to 2315 487 to 39   AAA   449/449
(100 %)
21 diff
(95.4 %id)
AJ706746 heart .a 1868 to 2298 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
AJ709937 heart .a 1869 to 2315 1 to 447   AAA   447/447
(100 %)
3 diff
(99.4 %id)
DB511039 testis .a 1869 to 2313 1 to 445     Submitted on the opposite strand 445/445
(100 %)
6 diff
(98.7 %id)
W24178 lung .a 1878 to 2308 434 to 3     Submitted on the opposite strand 432/447
(96 %)
0 diff
(100 %id)
AI073453 pooled .a 1880 to 2319 441 to 2       440/441
(99 %)
7 diff
(98.5 %id)
CF529556 placenta .a 1881 to 2305 439 to 15   AAA   425/425
(100 %)
1 diff
(99.8 %id)
CA488535   .a 1887 to 2305 1 to 419   AAA   419/419
(100 %)
0 diff
(100 %id)
EC470514 Prostate .a 1890 to 1989 103 to 1       103/103
(100 %)
3 diff
(97.1 %id)
EC556766 Prostate .a 1890 to 1986 102 to 6       97/102
(95 %)
0 diff
(100 %id)
H17542 whole brain .a 1893 to 2309 436 to 14   AAA   423/424
(99 %)
11 diff
(97.5 %id)
DB533995 hippocampus .a 1896 to 2304 1 to 410     Submitted on the opposite strand 410/411
(99 %)
20 diff
(95.2 %id)
BG057072 anaplastic oligodendroglioma, brain .a 1897 to 2306 412 to 1       412/413
(99 %)
12 diff
(97.1 %id)
T12181   .a 1910 to 2042 138 to 1       138/140
(98 %)
13 diff
(90.8 %id)
R41239 whole brain .a 1914 to 2305 410 to 11   AAA   400/402
(99 %)
17 diff
(95.8 %id)
AA830521 germinal center B cell .a 1916 to 2305 428 to 39   AAA   390/390
(100 %)
14 diff
(96.5 %id)
AA962187 Kidney, kidney tumor .a 1916 to 2309 424 to 31   AAA   394/394
(100 %)
2 diff
(99.5 %id)
AA524636   .a 1918 to 2306 393 to 3       391/424
(92 %)
0 diff
(100 %id)
C01210   .a 1925 to 2148 1 to 228       228/235
(97 %)
12 diff
(94.9 %id)
EC457833 Prostate .a 1937 to 2028 1 to 92       92/92
(100 %)
0 diff
(100 %id)
T99781 liver and spleen .a 1938 to 2283 356 to 1   fully sequenced,   356/356
(100 %)
11 diff
(97.0 %id)
CN406872 embryonic stem cells, DMSO-treated H9 cellline .a 1941 to 2309 1 to 369       369/369
(100 %)
0 diff
(100 %id)
AW024161 Kidney .a 1942 to 2306 367 to 3       365/367
(99 %)
0 diff
(100 %id)
AA079483   .a 1944 to 2283 344 to 1       344/453
(75 %)
5 diff
(98.9 %id)
BI761881 pooled colon, kidney, stomach .a 1955 to 2311 1 to 359   AAA   359/359
(100 %)
3 diff
(99.2 %id)
TI_57148576   .a 1955 to 2311 34 to 392   AAA   359/392
(91 %)
6 diff
(98.5 %id)
BU520844 leiomyosarcoma, uterus .a 1966 to 2319 768 to 404   AAA Submitted on the opposite strand 365/921
(39 %)
0 diff
(100 %id)
AI418790 Prostate .a 1967 to 2036 70 to 1       70/70
(100 %)
0 diff
(100 %id)
AI568812 Prostate .a 1967 to 2315 370 to 22   AAA   349/349
(100 %)
2 diff
(99.5 %id)
AA399215.
matches multiple genes
  .a 1968 to 2306 341 to 3     also hits gene C13orf26 339/341
(99 %)
0 diff
(100 %id)
AA688388 normal prostate, Prostate .a 1968 to 2305 351 to 16   AAA   336/336
(100 %)
8 diff
(97.7 %id)
BF871088 lung_tumor .a 1973 to 2301 8 to 336       329/351
(93 %)
9 diff
(97.5 %id)
BQ012911 placenta .a 1976 to 2305 344 to 15   AAA   330/330
(100 %)
0 diff
(100 %id)
R47391   .a 1991 to 2285 294 to 1       294/294
(100 %)
10 diff
(96.6 %id)
AA853087 Bone, Hip .a 2008 to 2306 305 to 7       299/305
(98 %)
0 diff
(100 %id)
T95191 liver and spleen .a 2011 to 2309 1 to 299   AAA   299/299
(100 %)
5 diff
(98.4 %id)
BM069523 Islets of Langerhans, Pancreas .a 2011 to 2312 304 to 3   fully sequenced,   302/304
(99 %)
5 diff
(98.4 %id)
AW051164 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2026 to 2305 280 to 1       280/280
(100 %)
2 diff
(99.3 %id)
DW409715 Liver .a 2041 to 2309 17 to 285   AAA   269/285
(94 %)
10 diff
(96.5 %id)
AA533891 normal prostatic epithelial cells, Prostate .a 2042 to 2306 1 to 264       264/307
(85 %)
3 diff
(99.1 %id)
AA534153 normal prostatic epithelial cells, Prostate .a 2048 to 2305 1 to 258   AAA   258/258
(100 %)
4 diff
(98.5 %id)
AW270983 Kidney .a 2050 to 2305 256 to 1       256/256
(100 %)
4 diff
(98.5 %id)
AW137908   .a 2056 to 2305 267 to 18   AAA   250/260
(96 %)
1 diff
(99.7 %id)
N67095 cochlea, ear .a 2077 to 2306 235 to 6       230/239
(96 %)
0 diff
(100 %id)
CA433620 mixed .a 2081 to 2309 247 to 19   AAA   229/229
(100 %)
5 diff
(97.9 %id)
CA433676 mixed .a 2082 to 2305 242 to 19   AAA   224/224
(100 %)
0 diff
(100 %id)
Z38363 brain, total brain .a 2133 to 2305 173 to 1       173/183
(94 %)
0 diff
(100 %id)
BU861101 mixed (pool of 40 RNAs) .a 2136 to 2305 1 to 170   AAA   170/170
(100 %)
2 diff
(98.9 %id)
BG057073 anaplastic oligodendroglioma, brain .a 2138 to 2306 169 to 1       169/169
(100 %)
1 diff
(99.5 %id)
AA451741 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2148 to 2283 136 to 1       136/136
(100 %)
0 diff
(100 %id)
AW615241 Kidney .a 2173 to 2305 133 to 1       133/133
(100 %)
0 diff
(100 %id)
CD240351   .a 2192 to 2305 19 to 132       114/132
(86 %)
6 diff
(95.5 %id)
BX384877   .b 1 to 947 1 to 947   tiling clone,   947/947
(100 %)
3 diff
(99.7 %id)
BX384876   .b 1107 to 2069 962 to 1   tiling clone,   962/962
(100 %)
7 diff
(99.3 %id)
CR607363 B cells (Ramos cell line) Cot 25-normalized .c 1 to 2067 1 to 2067 exact tiling clone,   2067/2067
(100 %)
0 diff
(100 %id)
BX343018   .c 13 to 945 10 to 942       935/942
(99 %)
16 diff
(98.4 %id)
BX346330   .c 45 to 979 1 to 939       939/939
(100 %)
22 diff
(97.7 %id)
BX365686   .c 45 to 402 1 to 361       361/363
(99 %)
17 diff
(95.4 %id)
BU601213 mixed (pool of 40 RNAs) .d 1 to 2102 1 to 646   tiling clone, Suspected internal deletion 646/647
(99 %)
11 diff
(98.3 %id)
AB209065 brain .e 1 to 4248 1 to 4248 exact tiling clone,   4248/4248
(100 %)
6 diff
(99.9 %id)
BF990277 placenta_normal .e 25 to 543 1 to 519       519/530
(97 %)
14 diff
(97.4 %id)
BM698681 eye, fetal eyes .e 1074 to 1419 1 to 346       346/346
(100 %)
0 diff
(100 %id)
CV572834 cornea, eye .e 2402 to 2976 1 to 575   tiling clone,   575/575
(100 %)
2 diff
(99.7 %id)
AA243323 germinal center B cell .e 2596 to 2764 1 to 169       169/169
(100 %)
2 diff
(98.9 %id)
AA283611 germinal center B cell .e 2650 to 2957 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
CN406862 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 2797 to 3372 1 to 576   tiling clone,   576/576
(100 %)
0 diff
(100 %id)
BM670771 eye, fetal eyes .e 3695 to 4254 578 to 19   tiling clone, AAA   560/560
(100 %)
2 diff
(99.7 %id)
AA283612 germinal center B cell .e 4075 to 4222 148 to 1       148/148
(100 %)
0 diff
(100 %id)
AA243324 germinal center B cell .e 4105 to 4249 147 to 3       145/147
(98 %)
0 diff
(100 %id)
BI753465 brain .f 1 to 756 1 to 756   tiling clone,   756/756
(100 %)
5 diff
(99.4 %id)
TI_57218098   .f 1 to 756 30 to 785       756/785
(96 %)
11 diff
(98.6 %id)
CX871299 embryonic stem .f 552 to 1322 1 to 770   tiling clone,   770/770
(100 %)
1 diff
(99.9 %id)
BF204300 muscle, rhabdomyosarcoma .g 1 to 777 1 to 777   tiling clone,   777/853
(91 %)
25 diff
(97.1 %id)
AI245464 Kidney .g 11 to 257 256 to 10       247/256
(96 %)
0 diff
(100 %id)
BF590918 colon, colon tumor, RER+ .g 12 to 215 204 to 1       204/204
(100 %)
0 diff
(100 %id)
AI948988 2 pooled tumors (clear cell type), Kidney .g 13 to 215 203 to 1       203/203
(100 %)
0 diff
(100 %id)
BM557935 astrocytoma grade IV, cell line, brain .g 196 to 971 1 to 783   tiling clone,   783/998
(78 %)
8 diff
(99.2 %id)
BM551792 astrocytoma grade IV, cell line, brain .g 196 to 1109 1 to 916 A220G K221Q L254P G255W G256R ... tiling clone,   916/1129
(81 %)
20 diff
(98.3 %id)
BP209447 cerebellum .h 1 to 583 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
BP209556 cerebellum .h 1 to 582 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AI948660 Kidney .h 105 to 305 201 to 1       201/201
(100 %)
2 diff
(99.1 %id)
DR004397 placenta .h 156 to 821 6 to 670       665/670
(99 %)
13 diff
(98.1 %id)
CN406865 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 196 to 804 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BF316991 brain, neuroblastoma .h 206 to 774 1 to 570       570/874
(65 %)
12 diff
(98.7 %id)
BG475081 melanotic melanoma, skin .h 230 to 992 1 to 763   tiling clone,   763/765
(99 %)
22 diff
(97.2 %id)
BE730277 melanotic melanoma, skin .h 231 to 1027 12 to 797 A7P A8P P9R A10W G11E ... tiling clone,   786/857
(91 %)
22 diff
(97.5 %id)
BF315506 brain, neuroblastoma .h 232 to 670 1 to 456       429/456
(94 %)
11 diff
(97.6 %id)
BE728764 melanotic melanoma, skin .h 251 to 1016 1 to 753   tiling clone,   753/989
(76 %)
22 diff
(97.8 %id)
BE268264 Burkitt lymphoma, lymph .i 1 to 588 18 to 612   tiling clone,   595/612
(97 %)
12 diff
(98.1 %id)
BE268925 Burkitt lymphoma, lymph .i 1 to 663 26 to 686       661/688
(96 %)
15 diff
(97.9 %id)
BE297843 muscle, rhabdomyosarcoma .i 1 to 727 19 to 749       731/774
(94 %)
35 diff
(95.5 %id)
BE397577 Burkitt lymphoma, lymph .i 1 to 632 24 to 655       632/655
(96 %)
6 diff
(99.1 %id)
BE268530 Burkitt lymphoma, lymph .i 9 to 689 24 to 704       681/706
(96 %)
18 diff
(97.5 %id)
BE268395 Burkitt lymphoma, lymph .i 10 to 624 28 to 648       621/648
(95 %)
16 diff
(97.6 %id)
BE562061 Burkitt lymphoma, lymph .i 12 to 754 27 to 761       735/763
(96 %)
19 diff
(97.6 %id)
BI225609 Burkitt lymphoma, lymph .i 21 to 709 1 to 687       687/695
(98 %)
6 diff
(99.2 %id)
BI226255 Burkitt lymphoma, lymph .i 21 to 736 1 to 714       714/913
(78 %)
22 diff
(97.6 %id)
BI225787 Burkitt lymphoma, lymph .i 21 to 852 1 to 829 A89C Q160R A161L S162P P163R ... tiling clone,   829/829
(100 %)
8 diff
(99.1 %id)
BI226565 Burkitt lymphoma, lymph .i 21 to 803 1 to 781   tiling clone,   781/782
(99 %)
8 diff
(99.0 %id)
BE397352 Burkitt lymphoma, lymph .i 25 to 803 42 to 817   tiling clone,   776/819
(94 %)
14 diff
(98.3 %id)
BE267843 Burkitt lymphoma, lymph .i 41 to 719 1 to 673       673/680
(98 %)
12 diff
(98.3 %id)
BF095261 uterus_tumor .j 1 to 384 395 to 12   tiling clone,   384/402
(95 %)
0 diff
(100 %id)
AW370001 breast .j 338 to 997 673 to 17   tiling clone,   657/692
(94 %)
7 diff
(99.0 %id)
TI_154134674   .k-u 1 to 558 65 to 628 exact tiling clone, Submitted on the opposite strand 564/1191
(47 %)
15 diff
(98.8 %id)
CN413116 embryonic stem cells, cell lines H1, H7, andH9 .k-u 134 to 860 1 to 726   tiling clone,   726/726
(100 %)
5 diff
(99.4 %id)
AI361353 brain, glioblastoma (pooled) .l 1 to 693 450 to 1 G94S A95H R96E G97A L98Q ... tiling clone, Suspected internal deletion 450/450
(100 %)
0 diff
(100 %id)
BM546925 ovary (pool of 3) .m 1 to 873 27 to 909 L78F V79G G80X N81G D82M ... tiling clone,   883/1044
(84 %)
19 diff
(98.2 %id)
BM714804 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene ILVBL, variant not shown         This clone was ignored    
BM669765 eye, fetal eyes Gene ILVBL, variant not shown       AAA This clone was ignored    
BM699107 eye, fetal eyes Gene ILVBL, variant not shown         This clone was ignored    
DB469490 hippocampus Gene ILVBL, variant not shown         This clone was ignored    
CD365005 Alveolar Macrophage, lung Gene ILVBL, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CN406863 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene ILVBL, variant not shown         This clone was ignored    
DB018858 esophageal, tumor tissue Gene ILVBL, variant not shown       capped This clone was ignored    
AW140103   Gene ILVBL, variant not shown         This clone was ignored    
BF309426 muscle, rhabdomyosarcoma Gene ILVBL, variant not shown         This clone was ignored    
BG718137 testis Gene ILVBL, variant not shown         This clone was ignored    
BI603123 brain, hypothalamus Gene ILVBL, variant not shown         This clone was ignored    
BQ642892 lymph, lymphoma, cell line Gene ILVBL, variant not shown         This clone was ignored    
TI_45216543   Gene ILVBL, variant not shown         This clone was ignored    
BC000109 Placenta, choriocarcinoma Gene ILVBL, variant not shown       available from MGC, AAA This clone was ignored    
AI421801 brain, glioblastoma (pooled) Gene ILVBL, variant not shown         Suspected internal deletion, this clone was ignored    
BE278645 choriocarcinoma, placenta Gene ILVBL, variant not shown       available from MGC, This clone was ignored    
BE278277 choriocarcinoma, placenta Gene ILVBL, variant not shown         This clone was ignored    
BM549997 leukocyte Gene ILVBL, variant not shown         Suspected internal deletion, this clone was ignored    
TI_227714299   Gene ILVBL, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI